🔗 Share this article

Treasury head Reeves has stated she is planning "targeted action to tackle household expense pressures" in the forthcoming Budget.

Speaking to media outlets, she stated that reducing price rises is a joint duty of both the administration and the central bank.

The United Kingdom's inflation rate is forecast to be the highest among the G7 advanced economies this year and next.

Potential Utility Bill Measures

Reports indicate the government could intervene to lower utility costs, such as by cutting the current 5% level of VAT applied on energy supplies.

An additional option is to lower some of the regulatory levies currently added to household expenses.

Fiscal Limitations and Analyst Predictions

The government will obtain the latest assessment from the official forecaster, the OBR, on the start of the week, which will reveal how much space there is for these actions.

The view from most economists is that the Chancellor will have to introduce tax increases or expenditure reductions in order to fulfill her voluntary fiscal targets.

Earlier on the same day, calculations showed there was a twenty-two billion pound shortfall for the chancellor to address, which is at the lower end of forecasts.

"It is a joint responsibility between the Bank of England and the administration to continue tackling some of the drivers of inflation," Reeves stated to the BBC in the US capital, at the yearly gatherings of the IMF and global financial institution.

Tax Commitments and International Issues

While a great deal of the attention has been on probable tax increases, the Treasury chief said the latest data from the OBR had not changed her commitment to manifesto promises not to increase rates on earnings tax, sales tax or National Insurance.

She blamed an "unpredictable global environment" with rising international and trade tensions for the fiscal tax moves, likely to be targeted on those "wealthiest."

International Economic Disputes

Referring to apprehensions about the United Kingdom's commercial links with the Asian nation she said: "Our security interests invariably come first."

Last week's statement by Chinese authorities to tighten export controls on rare earths and other resources that are crucial for high-technology production led American leader Donald Trump to suggest an extra 100% tariff on imports from China, raising the prospect of an full-scale trade war between the two largest economies.

The American finance chief labeled China's move "economic coercion" and "a global supply chain power grab."

Inquired about accepting the American proposal to participate in its dispute with the Asian nation, the Chancellor said she was "extremely troubled" by China's measures and urged the Chinese government "to avoid restrictions and restrict access."

She said the move was "harmful for the world economy and causes additional challenges."

"In my view there are areas where we must challenge Chinese policies, but there are also significant opportunities to export to China's economy, including financial services and other sectors of the economic system. We've got to get that balance correct."

The chancellor also stated she was working with other major economies "regarding our own essential resources approach, so that we are less reliant."

Health Service Drug Pricing and Funding

Reeves also admitted that the price the National Health Service pays for pharmaceuticals could increase as a consequence of current negotiations with the Trump administration and its drugs companies, in return for reduced taxes and investment.

Some of the world's largest pharmaceutical manufacturers have said in recent statements that they are either delaying or scrapping operations in the United Kingdom, with some attributing the insufficient payments they are getting.

Recently, the government science advisor said the cost the NHS spends on medicines would must go up to halt firms and drug research funding leaving the UK.

The Chancellor informed the BBC: "It has been observed because of the cost structure, that clinical trials, new drugs have not been offered in the United Kingdom in the manner that they are in other continental states."

"We want to guarantee that patients receiving care from the National Health Service are able to receive the top critical drugs in the globe. And so we are examining this situation, and... aiming to attract additional capital into Britain."